Tetracyclines, chloramphenicol, erythromycin, and clindamycin

Area of Science:

• Pharmacology
• Infectious Diseases
• Microbiology

Background:

• Antibiotics are crucial for treating bacterial infections.
• Understanding the spectrum of activity and side effects of antibiotics is vital for effective patient care.

Purpose of the Study:

• To review the in vitro activity of tetracyclines, chloramphenicol, erythromycin, and clindamycin.
• To outline the primary clinical indications for each antibiotic class.
• To describe the significant adverse effects associated with these antibiotics.

Main Methods:

• Literature review of antibiotic properties.
• Summary of in vitro antimicrobial spectrum.
• Compilation of clinical uses and toxicities.

Main Results:

• Tetracyclines are effective against Chlamydia, Mycoplasma pneumoniae, Brucella, rickettsiae, and Nocardia.
• Chloramphenicol is indicated for anaerobic infections, Haemophilus influenzae meningitis, and Salmonella typhi.
• Erythromycin targets M. pneumoniae, Legionella, Streptococcus pneumoniae, and group A streptococci; it's also used for bacterial endocarditis prophylaxis and rheumatic fever recurrence in penicillin-allergic patients.
• Clindamycin is primarily for anaerobic infections.

Conclusions:

• Each antibiotic class has a distinct spectrum of activity and specific indications.
• Adverse effects range from gastrointestinal upset and phototoxicity (tetracyclines) to bone marrow suppression (chloramphenicol), cholestatic hepatitis (erythromycin estolate), and pseudomembranous colitis (clindamycin).
• Caution is advised with tetracyclines in renal insufficiency and pregnancy due to potential fetal effects.